$0.3270
-0.0429-11.6%
最終更新: Nov 5, 8:35 AM
Benzinga
Benzinga
Benzinga
木曜日, 11 05
Benzinga
© 2026 Benzinga | All Rights Reserved
Actuate Therapeutics (ACTU) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.20 | $-0.21 | $-0.21 | $-0.27 |
| Actual | $-0.20 | $-0.24 | $-0.18 | $-0.25 |
| Surprise | 0.00% | -14.3% | +14.3% | +7.41% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.17 | $-0.17 | $-0.16 | $-0.15 |
| Revenue | ||||
| Consensus | — | — | — | — |
| 会計四半期 | 報告日 | 実質EPS | 推定EPS | 驚き ％ |
|---|---|---|---|---|
| Q2 | Aug 14, 2026 | $-0.20 | $-0.20 | 0.00 % |
| Q1 | May 14, 2026 | $-0.24 | $-0.21 | -14.3 % |
| Q4 | Mar 26, 2026 | $-0.18 | $-0.21 | 14.3 % |
| Q3 | Nov 13, 2025 | $-0.25 | $-0.27 | 7.41 % |